Company · CIK 0001783032
Elevation Oncology, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001140361-25-026864 · 555.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-009062 · 164.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-25-057620 · 1.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-007806 · 266.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-25-007801 · 8.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-006298 · 172.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-004491 · 181.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-004266 · 178.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-25-025878 · 231.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-003305 · 168.2 KBSEC(opens sec.gov)
Insiders
- Adelman Robert J10% Owner
- Aisling Capital IV, LP10% Owner
- Carruthers R MichaelDirector
- Chen Bihua10% Owner
- Cherrington Julie MDirector
- CLACKSON TIMOTHY PDirector
- Cormorant Asset Management, LPFormer 10% Owner
- Cormorant Private Healthcare Fund III LP10% Owner
- Dornan DavidCHIEF SCIENTIFIC OFFICER
- ELMS STEVEDirector
Tickers
No tickers on record.
Addresses
business
101 FEDERAL STREET SUITE 1900
BOSTON, MA, 02110
mailing
101 FEDERAL STREET SUITE 1900
BOSTON, MA, 02110
Former names
- 14ner Oncology, Inc.2019-07-19
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies